Analysis of Factors Associated with Outcome in Patients Undergoing Isolated Hepatic Perfusion for Unresectable Liver Metastases from Colorectal Center

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Annals of Surgical Oncology

• Publication date

  2009-05-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1245/s10434-009-0482-9PMID 19434456PMCID PMC8381241
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxaliplatin plus irinotecan compared with irinotecan alone as second-line treatment after single-agent fluoropyrimidine therapy for metastatic colorectal carcinoma.

  2008cited by this paper
• Cetuximab for the treatment of colorectal cancer.

  2007cited by this paper
• The continuum of care: a paradigm for the management of metastatic colorectal cancer.

  2007cited by this paper
• Complete response of colorectal liver metastases after chemotherapy: does it mean cure?

  2006cited by this paper
• Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial.

  2006cited by this paper
• Treatment with 5-Fluorouracil/Folinic Acid, Oxaliplatin, and Irinotecan Enables Surgical Resection of Metastases in Patients With Initially Unresectable Metastatic Colorectal Cancer

  2006cited by this paper
• Isolated Hepatic Perfusion for the Treatment of Patients With Colorectal Cancer Liver Metastases After Irinotecan-Based Therapy

  2005cited by this paper
• Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study.

  2005cited by this paper
• Current Approaches to First-Line Treatment of Advanced Colorectal Cancer

  2004cited by this paper
• Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.

  2004cited by this paper
• Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.

  2004cited by this paper
• Current status of second-line therapy for metastatic colorectal cancer.

  2004cited by this paper
• Phase II study of CC-4047 in patients with metastatic hormone-refractory prostate cancer (HRPCa).

  2004cited by this paper
• Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment.

  2004cited by this paper
• Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

  2004cited by this paper
• The past decade of experience with isolated hepatic perfusion.

  2004cited by this paper
• Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial.

  2003cited by this paper
• Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF.

  2002cited by this paper
• Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer.

  2001cited by this paper
• Role of tumor necrosis factor on toxicity and cytokine production after isolated hepatic perfusion.

  2001cited by this paper
• Current status of isolated hepatic perfusion with or without tumor necrosis factor for the treatment of unresectable cancers confined to liver.

  2000cited by this paper
• Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies.

  2000cited by this paper
• Hyperthermic isolated limb perfusion with tumor necrosis factor alone for melanoma.

  1995cited by this paper
• Continuous intraoperative external monitoring of perfusate leak using iodine-131 human serum albumin during isolated perfusion of the liver and limbs

  1995cited by this paper
• Factors influencing the natural history of colorectal liver metastases.

  1994cited by this paper
• Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal vein

  1987cited by this paper
• Modulation of endothelial cell hemostatic properties by tumor necrosis factor

  1986cited by this paper
• The blood supply of neoplasms in the liver.

  1954cited by this paper

• Hepatic Perfusion for Diffuse Metastatic Cancer to the Liver: Open and Percutaneous Techniques.

  2025cites this paper
• Repeated use of hybrid isolated chemoperfusion with melphalan in non-resectable liver malignancy

  2024cites this paper
• Isolated liver chemoperfusion in a patient with mesenteric leiomyosarcoma and liver metastasis

  2024cites this paper
• Measuring behavioral synchronization and spatial cohesion in the activity budgets of three adult white-handed gibbon (Hylobates lar) dyads in Huai Kha Khaeng Wildlife Sanctuary, Thailand.

  2024cites this paper
• Experience of cytokine therapy in the treatment of recurrent cervical cancer

  2023cites this paper
• Hepatic Perfusion for Diffuse Metastatic Cancer to the Liver: Open and Percutaneous Techniques.

  2021cites this paper
• Bringing Macrophages to the Frontline against Cancer: Current Immunotherapies Targeting Macrophages

  2021cites this paper
• Isolated and Percutaneous Hepatic Perfusion for Unresectable Liver Metastases: A Systematic Review

  2021influential citation
• A New Option for the Treatment of Intrahepatic Cholangiocarcinoma: Percutaneous Hepatic Perfusion with CHEMOSAT Delivery System

  2021cites this paper
• Chemosaturation with percutaneous hepatic perfusion is effective in patients with ocular melanoma and cholangiocarcinoma

  2020cites this paper
• Onkologische Embolisation

  2020cites this paper
• Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma

  2019cites this paper
• Current Trends in the Surgical Management of Colorectal Cancer Liver Metastases

  2019cites this paper
• The History of Isolated Hepatic Perfusion for Liver Metastases and Current Indications for Use

  2019cites this paper
• Hepatic Perfusion: Surgical and Catheter

  2019cites this paper
• Isolated Hyperthermic Hepatic Chemoperfusion in Patients with Colorectal Cancer and Isolated Non-Resectable Liver Metastases

  2018cites this paper
• Safety and efficacy of chemosaturation in patients with primary and secondary liver tumors

  2017cites this paper
• Isolated Hepatic Perfusion with Melphalan for Primary or Metastatic Unresectable Cancers of the Liver: Safety and Feasibility in A U.S. Academic Medical Center

  2017cites this paper
• Recent Developments in Isolated Hepatic Perfusion as an Alternative in the Treatment of Unresectable Metastatic Liver Disease Secondary to Colorectal Cancer

  2016cites this paper
• Hepatic Perfusion Therapy.

  2016cites this paper
• Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk

  2015cites this paper
• Retrograde-outflow percutaneous isolated hepatic perfusion using cisplatin: A pilot study on pharmacokinetics and feasibility

  2015cites this paper
• Priming neuroblastoma for cisplatin and etoposide drug therapy

  2015cites this paper
• Hemodynamics in rat liver tumor model during retrograde-outflow isolated hepatic perfusion with aspiration from the portal vein: angiography and in vivo microscopy

  2014cites this paper
• Cratoxylum formosum (Jack) Dyer ssp. pruniflorum (Kurz) Gogel. (Hóng yá mù) extract induces apoptosis in human hepatocellular carcinoma HepG2 cells through caspase-dependent pathways

  2014cites this paper
• Chemosaturation with Percutaneous Hepatic Perfusions of Melphalan for Hepatic Metastases: Experience from Two European Centers

  2014cites this paper
• Isolated hepatic perfusion: principles and results.

  2014cites this paper
• Outcome Analysis of a Decade-Long Experience of Isolated Hepatic Perfusion for Unresectable Liver Metastases at a Single Institution

  2014cites this paper
• Isolated hepatic perfusion for patients with liver metastases

  2014cites this paper
• Interventional treatment for unresectable hepatocellular carcinoma.

  2014cites this paper
• Foie isolé perfusé : principes et résultats ☆

  2014cites this paper
• Chemosaturation with Percutaneous Hepatic Perfusions of Melphalan for Hepatic Metastases: Experience from Two European Centers Chemosaturation mittels perkutaner hepatischer Perfusion von Melphalan zur Behandlung von Lebermetastasen: Erfahrungen von zwei europäischen Zentren

  2014cites this paper
• Tumour necrosis factor and cancer

  2013cites this paper
• Perfusion hyperthermique du foie isolé avec melphalan et bévacizumab

  2013cites this paper
• Hyperthermic isolated liver perfusion with melphalan and bevacizumab.

  2013cites this paper
• Can metastatic colorectal cancer be cured?

  2012cites this paper
• A Middle-aged Woman With Morbid Obesity – How to Treat ?

  2012cites this paper
• Chapter 89 – Isolated hepatic perfusion for extensive liver cancer

  2012cites this paper
• Isolated hepatic perfusion for the treatment of liver metastases.

  2012cites this paper
• Colorectal Liver Metastases

  2011cites this paper
• Regional chemotherapy in primary and secondary liver cancer

  2011cites this paper
• Advances in regional chemotherapy of the liver

  2011cites this paper
• Hypoxic Single-Pass Isolated Hepatic Perfusion of Hypotonic Cisplatin: Safety Study in the Pig

  2010cites this paper
• Percutaneous isolated liver perfusion with occlusion balloons and a catheter-based stent-graft-like perfusion device: an experimental study in a porcine model

  2010cites this paper
• Regional treatment of colorectal liver metastasis

  2010cites this paper
• Development of Isolated Hepatic Perfusion via the Operative and Percutaneous Techniques for Patients With Isolated and Unresectable Liver Metastases

  2010cites this paper